Nephro Care India Ltd
Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes
in the treatment of kidney- related diseases[1]
- Market Cap ₹ 220 Cr.
- Current Price ₹ 133
- High / Low ₹ 379 / 124
- Stock P/E 74.6
- Book Value ₹ 32.1
- Dividend Yield 0.00 %
- ROCE 60.4 %
- ROE 49.1 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 59.5%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|
0.54 | 1.82 | 3.42 | 17.09 | 27.23 | 31.82 | |
0.52 | 1.67 | 3.28 | 13.66 | 20.76 | 26.06 | |
Operating Profit | 0.02 | 0.15 | 0.14 | 3.43 | 6.47 | 5.76 |
OPM % | 3.70% | 8.24% | 4.09% | 20.07% | 23.76% | 18.10% |
0.01 | 0.01 | -0.01 | 0.00 | 0.28 | 0.79 | |
Interest | 0.04 | 0.03 | 0.02 | 0.07 | 0.09 | 0.09 |
Depreciation | 0.00 | 0.01 | 0.11 | 0.78 | 0.53 | 0.98 |
Profit before tax | -0.01 | 0.12 | 0.00 | 2.58 | 6.13 | 5.48 |
Tax % | 0.00% | 25.00% | 7.75% | 28.06% | ||
-0.01 | 0.09 | -0.01 | 2.37 | 4.41 | 2.95 | |
EPS in Rs | -10.00 | 90.00 | -0.20 | 47.40 | 3.71 | 1.97 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 146% |
TTM: | 59% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 263% |
TTM: | 82% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 60% |
Last Year: | 49% |
Balance Sheet
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.50 | 0.50 | 11.90 | 16.49 |
Reserves | 0.07 | 0.01 | 0.00 | 2.03 | 3.12 | 36.46 |
0.40 | 0.69 | 2.54 | 2.48 | 0.00 | 0.00 | |
0.30 | 0.42 | 1.60 | 3.25 | 5.94 | 14.21 | |
Total Liabilities | 0.78 | 1.13 | 4.64 | 8.26 | 20.96 | 67.16 |
0.45 | 0.06 | 1.39 | 3.01 | 4.74 | 5.70 | |
CWIP | 0.00 | 0.45 | 1.90 | 0.00 | 0.86 | 17.78 |
Investments | 0.24 | 0.00 | 0.00 | 2.00 | 6.51 | 25.03 |
0.09 | 0.62 | 1.35 | 3.25 | 8.85 | 18.65 | |
Total Assets | 0.78 | 1.13 | 4.64 | 8.26 | 20.96 | 67.16 |
Cash Flows
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
0.23 | 0.62 | 4.12 | 0.91 | ||
-0.06 | -2.81 | -2.33 | -7.54 | ||
0.28 | 2.32 | -0.08 | 5.60 | ||
Net Cash Flow | 0.44 | 0.13 | 1.71 | -1.03 |
Ratios
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 0.00 | 0.00 | 20.28 | 0.85 | 2.01 |
Inventory Days | 8.83 | 41.93 | 35.25 | 14.07 | |
Days Payable | 94.19 | 113.45 | 69.03 | 75.17 | |
Cash Conversion Cycle | 0.00 | -85.36 | -51.24 | -32.93 | -59.09 |
Working Capital Days | -168.98 | -74.20 | -117.40 | -55.96 | -36.86 |
ROCE % | 25.21% | 1.60% | 65.84% | 60.41% |
Documents
Announcements
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
4 April 2025 - Nephro Care India Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
-
Structural Digital Database
4 April 2025 - SDD Compliance Certificate for the quarter ended on 31st March 2025.
-
Trading Window-XBRL
27 March 2025 - NEPHRO CARE INDIA LIMITED has informed about Closure of Trading Window
-
Trading Window
27 March 2025 - Nephro Care India Limited has informed regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
-
General Updates
27 March 2025 - Nephro Care India Limited has informed about General Updates
Business Overview:[1][2]
NCIL provides comprehensive medical services for renal patients as a one-stop treatment center in Kolkata. It offers clinical and lifestyle solutions for renal insufficiency, covering lifestyle, physiological, and spiritual wellness. The company specializes in non-invasive services.